Lexicon Pharmaceuticals | LXRX

Stock Price
2.83
Daily Change
-6.77%
Yearly
83.44%
Q2 Forecast
2.67
Rating
Sell

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Peers Price Day Year
Abbott 101.68 0.91 0.90% -7.25%
Acadia Pharmaceuticals 24.72 -0.37 -1.47% 44.65%
Acorda Therapeutics 10.03 -0.81 -7.47% 2,611.54%
Agios Pharmaceuticals 25.87 -0.73 -2.74% 39.84%
Akebia Therapeutics 1.26 0.01 0.80% 209.13%
Alnylam Pharmaceuticals 190.83 0.40 0.21% 44.45%
AstraZeneca 11,712.00 -38.00 -0.32% 18.89%
Bluebird Bio 3.65 -0.11 -2.93% -14.52%
BioMarin Pharmaceutical 91.37 -0.89 -0.96% 21.70%
Coherus Biosciences 5.42 0.03 0.56% -19.35%
Esperion Therapeutics 1.30 -0.05 -3.70% -76.23%
Halozyme Therapeutics 33.96 -0.20 -0.59% -22.45%
Intercept Pharmaceuticals 11.85 -0.40 -3.27% -6.55%
Illumina 200.53 -2.19 -1.08% -1.79%
Insmed 19.80 -0.23 -1.15% 8.37%
Ironwood Pharmaceuticals 11.42 -0.18 -1.55% -2.81%
J&J 160.01 -0.25 -0.16% -7.27%
Eli Lilly 446.04 0.38 0.09% 50.18%
Lexicon Pharmaceuticals 2.83 -0.21 -6.77% 83.44%
MacroGenics 5.56 0.36 6.92% 98.57%
MannKind 4.03 -0.09 -2.18% -7.36%
Merck & Co 110.71 0.39 0.35% 26.99%
Moderna 123.26 -1.68 -1.34% -3.04%
Novartis 90.17 -0.20 -0.22% 7.45%
Puma Biotechnology 3.38 -0.13 -3.70% 30.50%
PTC Therapeutics 43.00 0.44 1.03% 60.45%
Ultragenyx Pharmaceutical 51.38 -0.20 -0.39% 3.01%
Regulus Therapeutics 1.35 -0.07 -4.93% 425.50%
Sarepta Therapeutics 127.67 1.76 1.40% 84.63%
Thermo Fisher Scientific 518.18 2.93 0.57% -1.65%
United Therapeutics 228.49 1.99 0.88% 3.55%
Vanda Pharmaceuticals 6.50 0 0% -33.47%

Indexes Price Day Year
USND 13259 20.62 0.16% 16.92%
US2000 1866 -15.07 -0.80% 3.63%

Lexicon Pharmaceuticals

Lexicon Pharmaceuticals traded at $2.83 this Friday June 9th, decreasing $0.21 or 6.77 percent since the previous trading session. Looking back, over the last four weeks, Lexicon Pharmaceuticals lost 7.98 percent. Over the last 12 months, its price rose by 83.44 percent. Looking ahead, we forecast Lexicon Pharmaceuticals to be priced at 2.67 by the end of this quarter and at 2.44 in one year, according to Trading Economics global macro models projections and analysts expectations.

Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of treatments for human diseases. The Company's drug programs include Sotagliflozin, LX9211 and LX2761. LX9211 is an orally-delivered small molecule compound that is being developed for the treatment of neuropathic pain. The Company is conducting a Phase II clinical trial of LX9211 in diabetic peripheral neuropathic pain and a second Phase II clinical trial of LX9211 in post-herpetic neuralgia. Sotagliflozin is an orally-delivered small molecule compound that is being developed for the treatment of type I diabetes and type II diabetes, heart failure and chronic kidney disease. LX2761 is an orally-delivered small molecule compound that is designed to inhibit sodium-glucose cotransporter 1 (SGLT1) locally in the gastrointestinal tract without any inhibition of sodium-glucose cotransporter 2 (SGLT2) in the kidney.